Preprint
Article

This version is not peer-reviewed.

Psychological Inflexibility and Quality of Life in Breast Cancer

Submitted:

01 April 2026

Posted:

03 April 2026

You are already at the latest version

Abstract
emotional distress and diminished quality of life (QoL), yet the indirect pathways linking PI to QoL through distress remain largely untested in breast cancer. Methods: This exploratory secondary analysis used a publicly available longitudinal dataset of 40 women with non-metastatic breast cancer assessed at baseline and 2-month follow-up. Bootstrapped mediation (5,000 resamples, BCa CIs) tested whether depression, anxiety, and stress (DASS-21) statistically mediated the association between PI (AAQ-II) and QoL (WHOQOL-BREF) across 27 models. Hierarchical regressions, Kruskal–Wallis tests, and extended correlations supplemented the analysis. Results: At follow-up, all nine cross-sectional indirect effects were significant (all 95% BCa CIs excluding zero), with distress accounting for 33–51% of the total association between PI and QoL. The largest indirect effects were observed for depression on psychological QoL (indirect = −0.845, p < .001) and anxiety on physical QoL (indirect = −0.739, p < .001). No indirect effects were significant at baseline or for change scores (all p > .05). Concurrent PI independently predicted psychological QoL (ΔR² = .094, p = .002), general QoL (ΔR² = .084, p = .015), and anxiety (ΔR² = .122, p = .004) in hierarchical regressions. Anxiety severity was associated with impairment across all five QoL domains (all p_adj < .05). Conclusions: These preliminary findings suggest that emotional distress may partially account for the association between PI and QoL in breast cancer, consistent with predictions from the ACT model. However, the small sample size and cross-sectional nature of the follow-up indirect effects preclude causal inference. Replication in adequately powered prospective designs is essential.
Keywords: 
;  ;  ;  ;  ;  

1. Introduction

Breast cancer is the most frequently diagnosed malignancy among women worldwide, accounting for approximately 2.3 million new cases and 670,000 deaths in 2022 [1]. Beyond the direct physical consequences of the disease and its treatment, breast cancer imposes a substantial psychological burden characterised by depression, anxiety, stress, sleep disturbances, altered body image, and diminished quality of life (QoL) [2]. Systematic reviews have demonstrated that breast cancer survivors face significantly elevated risks of depression, anxiety, and suicidal ideation compared to women without a cancer history [3], and meta-analytic evidence indicates that these comorbidities adversely affect both cancer prognosis and all-cause mortality [4]. Indeed, a meta-analysis of 94 interview-based studies estimated that mood disorders affect 30–40% of patients in oncological settings, with prevalence rising further when self-report measures are used [5]. These findings underscore the need for transdiagnostic theoretical frameworks that elucidate the psychological mechanisms underlying emotional distress and QoL impairment in this population.
Acceptance and Commitment Therapy (ACT) provides such a framework by identifying psychological inflexibility (PI) as a core transdiagnostic process driving psychopathology [6]. PI is operationally defined as the rigid dominance of internal reactions over chosen values and goals, encompassing experiential avoidance—the tendency to suppress or escape unwanted thoughts, emotions, and bodily sensations—and is reliably measured by the Acceptance and Action Questionnaire-II (AAQ-II) [7]. According to the ACT model, PI maintains psychological distress not through the content of negative cognitions but through patterns of experiential avoidance that narrow behavioural repertoires and disconnect individuals from valued life domains [6,8].
Converging evidence supports the clinical relevance of this framework in oncology. A meta-analysis of randomised controlled trials demonstrated moderate-to-large effects of ACT on reducing depression, anxiety, and stress in breast cancer [10], and clinical trials have shown benefits for fear of recurrence [11] and pain acceptance [12]. Reductions in experiential avoidance have been identified as a key process through which psychological interventions are associated with improvements in anxiety, depression, and well-being [9,13], and PI has emerged as a consistent correlate of emotional distress across diverse clinical populations [14,15]. Despite these advances, whether emotional distress statistically accounts for the association between PI and QoL in breast cancer remains largely untested.
Trindade and colleagues provided preliminary longitudinal evidence for the role of experiential avoidance in breast cancer outcomes [16]. However, their analysis was restricted to three outcome variables, did not test mediation pathways, did not model anxiety as a dependent variable, and omitted multiple QoL domains from regression analyses. The present study addresses these gaps through a theory-driven secondary analysis of the dataset, employing mediation across all DASS-21 distress subscales and WHOQOL-BREF QoL domains. The aim is to examine whether emotional distress statistically accounts for the association between PI and health-related QoL in breast cancer patients and to characterise PI’s predictive associations across psychological and functional outcomes.

2. Materials and Methods

Data Source and Ethical Considerations. This study is a secondary analysis of a publicly available longitudinal dataset originally collected and reported by Trindade et al. [16]. The dataset is openly accessible via Mendeley Data [17]. As the dataset is publicly available and fully anonymised, no additional ethical approval was required for this secondary analysis. Study Design and Participants. A prospective longitudinal design with two assessment points was employed: baseline (M0) and 2-month follow-up (M2). The interval between assessments was approximately two months. The sample comprised 40 women diagnosed with non-metastatic breast cancer (stages I–III), aged 36 to 85 years (M = 60.00, SD = 10.13), recruited from the Radiotherapy Service of the University Coimbra Hospital (Centro Hospitalar Universitário de Coimbra), Coimbra, Portugal. The average time since diagnosis was 6.70 months (SD = 4.26). No participant was receiving psychosocial treatment during the study period. No demographic or clinical covariates beyond age and cancer stage were available in the public dataset. The original data collection was conducted by researchers affiliated with CINEICC (Center for Research in Neuropsychology and Cognitive and Behavioral Intervention), Faculty of Psychology and Educational Sciences, University of Coimbra. Measures. The Acceptance and Action Questionnaire–II (AAQ-II) is a 7-item self-report measure of psychological inflexibility and experiential avoidance [7]. Items are rated on a 7-point Likert scale (1 = never true to 7 = always true), with higher total scores indicating greater psychological inflexibility. The AAQ-II has demonstrated a single-factor structure, good internal consistency (mean α = .84 across six validation samples), and adequate 12-month test–retest reliability (α = .79) [7]. The Depression Anxiety Stress Scales–21 (DASS-21) [18] is a 21-item self-report instrument assessing three dimensions of negative emotional states: depression (7 items), anxiety (7 items), and stress (7 items). Items are rated on a 4-point severity/frequency scale (0 = did not apply to me at all to 3 = applied to me very much or most of the time). Subscale scores are computed by summing item responses and multiplying by two to correspond with the full DASS-42 norms. Higher scores indicate greater symptom severity. Clinical severity classifications (normal, mild, moderate, severe, extremely severe) follow the previously validated cut-offs [18]. The World Health Organization Quality of Life–BREF (WHOQOL-BREF) [19] is a 26-item generic quality of life instrument assessing four domains: physical health (7 items), psychological (6 items), social relationships (3 items), and environment (8 items), plus two items assessing overall quality of life and general health satisfaction. Domain scores are transformed to a 0–100 scale, with higher scores indicating better quality of life. Internal consistency in the present sample ranged from α = .64 to .90 across domains and timepoints [16]. Mediation analysis. Guided by the ACT model of psychological inflexibility [6] and meta-analytic evidence linking experiential avoidance to depression (r = .56) and anxiety (r = .51) [20], we tested whether DASS-21 subscales mediated the relationship between AAQ-II and WHOQOL-BREF domains. Three mediators (depression, anxiety, stress) were crossed with three theoretically grounded QoL outcomes: physical (continuity with the original study [16]), psychological (strongest ACT-theorised link) [21], and general (global QoL indicator). Social and environmental domains were excluded from mediation analyses due to weaker theoretical grounding in the inflexibility–distress pathway [21]. This yielded 27 planned models (3 mediators × 3 outcomes × 3 timepoints: baseline, follow-up, and change scores); all combinations were retained to enable evaluation of the full pattern across timepoints rather than selectively reporting significant results. Mediation was tested using the mediation package in R [22] with 5,000 bootstrap resamples and bias-corrected accelerated (BCa) confidence intervals. Significance was determined by whether the 95% BCa CI excluded zero. As the mediator and outcome were measured concurrently at each timepoint, these models estimate cross-sectional indirect effects and do not support causal inference [28]. Statistical analysis. Five outcomes not examined by Trindade et al. [16] were tested in hierarchical multiple regression: WHOQOL-BREF psychological, social, environmental, and general domains, and DASS-21 anxiety. For each outcome, a three-step model was fitted: Step 1 entered the baseline score of the dependent variable as an autoregressive control; Step 2 added concurrent psychological inflexibility (AAQ-II at M2); Step 3 added baseline psychological inflexibility (AAQ-II at M0) to evaluate the incremental predictive value of earlier inflexibility levels. DASS-21 subscale scores were classified into clinical severity bands (normal, mild, moderate, severe, extremely severe) following the manual cut-offs [18]. Between-group differences in WHOQOL-BREF domain scores across severity categories were tested using Kruskal–Wallis tests, with Benjamini–Hochberg correction for multiple comparisons applied across the 15 tests (3 DASS subscales × 5 QoL domains). Pearson correlation matrices were computed at baseline, follow-up, and for change scores (Δ = M2 − M0), including variables omitted from Trindade et al.’s [16] original correlation table. Pearson coefficients were chosen for comparability with the original study; given the non-normal distributions of several variables, these should be interpreted with caution. Baseline-to-follow-up changes were evaluated using paired t-tests for variables with normally distributed difference scores and Wilcoxon signed-rank tests where Shapiro–Wilk tests indicated significant departures from normality. Effect sizes were computed as Cohen’s d for paired samples. All analyses were conducted in R (version 4.3). Statistical significance was set at α = .05 throughout, with corrections for multiple comparisons applied where indicated.

3. Results

3.1. Descriptive Statistics

Table A1 presents descriptive statistics for all study variables at baseline (M0) and 2-month follow-up (M2). Participants reported moderate levels of psychological inflexibility at baseline (AAQ-II: M = 17.35, SD = 9.32) and low-to-mild emotional distress across DASS-21 subscales (depression: M = 4.08, SD = 5.32; anxiety: M = 4.03, SD = 4.75; stress: M = 5.74, SD = 5.14). Quality of life scores were moderate across all WHOQOL-BREF domains, with psychological QoL highest (M = 69.48, SD = 19.11) and general QoL lowest (M = 61.88, SD = 15.75). Shapiro–Wilk tests indicated significant departures from normality for the AAQ-II and all three DASS-21 subscales at both timepoints (all p < .01), necessitating non-parametric alternatives where appropriate.

3.2. DASS-21 Clinical Severity Distribution

At baseline, the majority of participants fell within the normal range for depression (70.0%), anxiety (56.4%), and stress (69.2%). Nevertheless, a clinically meaningful minority presented with elevated symptomatology: 12.5% reported moderate depression and 7.5% endorsed extremely severe depressive symptoms, while 12.8% reported extremely severe anxiety. By follow-up, the proportion classified as normal increased notably for stress (from 69.2% to 85.0%), whereas distributions for depression and anxiety remained relatively stable (Table A2).

3.3. Temporal Stability: Paired Comparisons

No statistically significant changes were observed between M0 and M2 on any variable (Table A3). Effect sizes were uniformly small (|d| ≤ 0.28), indicating broad stability across the assessment interval. Physical QoL showed the largest positive trend (Δ = 3.57, d = 0.26, p = .103).

3.4. Internal Consistency

Individual item-level data were not available in the public dataset; therefore, internal consistency coefficients were not recomputed. Trindade et al. [16] reported acceptable to good reliability across all instruments in this sample (AAQ-II α = .93–.94; DASS-21 depression α = .91–.95; anxiety α = .73–.81; stress α = .83–.92; WHOQOL-BREF domains α = .64–.90).

3.5. Mediation Analysis

The hypothesised mediation model is depicted in Figure 1. Twenty-seven mediation models were tested, crossing three DASS-21 mediators with three WHOQOL-BREF outcomes at three timepoints. Results are summarised in Table A4 and Figure 2.
At baseline, none of the nine indirect effects reached statistical significance. The strongest trend was observed for the stress-mediated AAQ-II–general QoL indirect effect (indirect = 0.301, 95% BCa CI [−0.080, 0.546], p = .092), suggesting a potential but underpowered mediation effect. In contrast to baseline, all nine indirect effects at follow-up were statistically significant (Figure 2), suggesting a strengthening of the cross-sectional associations at this timepoint. Depression yielded a significant indirect effect on physical QoL (indirect = −0.661, 95% BCa CI [−1.195, −0.317], p = .002; 45.7% mediated), psychological QoL (indirect = −0.845, 95% BCa CI [−1.448, −0.365], p < .001; 47.7% mediated), and general QoL (indirect = −0.573, 95% BCa CI [−1.030, −0.131], p = .009; 44.5% mediated). Anxiety yielded the largest proportion mediated for physical QoL (51.1%), whilst stress showed the strongest indirect effect on the AAQ-II–general QoL association (48.8%). Proportions mediated at M2 ranged from 32.8% to 51.1%, indicating that emotional distress accounted for a substantial share of the total association between psychological inflexibility and quality of life. Figure 3 illustrates the depression indirect effect path at M2 as an exemplar.
No change-score mediation models yielded significant indirect effects (all p > .05), likely reflecting insufficient statistical power for detecting mediated effects in change scores with the present sample size [23]. Figure 4 illustrates the contrast across the three timepoint specifications.

3.6. Hierarchical Regression

Hierarchical regression analyses were conducted for five outcomes not examined in the original study (Table A5). Across all models, the baseline score of the dependent variable (Step 1) accounted for substantial variance (R² = .416–.698). The addition of concurrent psychological inflexibility (AAQ-II at M2) at Step 2 significantly improved model fit for psychological QoL (ΔR² = .094; B = −0.97, p = .002), general QoL (ΔR² = .084; B = −0.75, p = .015), and anxiety (ΔR² = .122; B = 0.26, p = .004). Environmental QoL showed a trend-level association (B = −0.51, p = .053) that reached significance at Step 3 (B = −0.64, p = .034). In contrast, concurrent inflexibility did not predict social QoL (B = −0.23, p = .472).
The inclusion of baseline inflexibility (AAQ-II at M0) at Step 3 contributed unique predictive variance only for anxiety (B = 0.20, p = .037), indicating that earlier psychological inflexibility was independently associated with subsequent anxiety symptoms, over and above concurrent inflexibility and baseline anxiety levels. For all QoL outcomes, baseline inflexibility did not add incrementally to prediction after accounting for concurrent inflexibility and the autoregressive effect (all p > .35).

3.7. DASS-21 Clinical Severity and Quality of Life

Kruskal–Wallis tests examined whether baseline QoL differed across DASS-21 clinical severity categories (Table A6; Figure 5). Anxiety severity was associated with statistically significant differences in all five QoL domains after Benjamini–Hochberg correction (all padj < .05), with social QoL showing the largest effect (H(4) = 20.41, padj = .006). Depression severity differentiated social QoL (H(4) = 16.67, padj = .016) and physical QoL (H(4) = 11.84, padj = .040), but not psychological, environmental, or general QoL after correction. Stress severity was associated only with social QoL (H(4) = 14.66, padj = .016). These results identify social QoL as the domain most consistently differentiated by emotional distress severity across all three DASS-21 subscales.
Pearson correlations (Supplementary Tables S6–S8) revealed that AAQ-II scores were strongly associated with all QoL domains at baseline (r = −.645 to −.805, all p < .001) and with DASS-21 subscales (r = .653–.714). At follow-up, associations between DASS-21 subscales and QoL domains strengthened considerably (e.g., depression–psychological QoL: r = −.563 at M0 vs. r = −.816 at M2), consistent with the emergence of significant mediation at M2. Change-score correlations were substantially attenuated; AAQ-II changes correlated significantly only with changes in psychological QoL (r = −.330, p = .038) and general QoL (r = −.327, p = .039).

4. Discussion

We conducted an exploratory secondary analysis of a publicly available longitudinal dataset [16,17] to examine whether emotional distress statistically accounts for the association between PI and QoL in women with non-metastatic breast cancer. Extending the original three-outcome analysis by Trindade et al. [16], we tested bootstrapped mediation across all DASS-21 distress dimensions and WHOQOL-BREF QoL domains, supplemented by hierarchical regression and clinical severity classification. To our knowledge, this is among the first studies to formally test indirect effects linking PI to multiple QoL domains through emotional distress in breast cancer, providing preliminary findings consistent with the ACT model [6]. All nine cross-sectional indirect effects at the two-month follow-up were significant, with emotional distress accounting for 33% to 51% of the total association between PI and QoL. This pattern is consistent with the ACT theoretical proposition that PI is associated with diminished functioning partly through elevated emotional distress [6,8], and the proportions mediated are broadly comparable to those reported in non-cancer populations [24,25]. In advanced cancer, Panjwani et al. [26] found that experiential avoidance statistically mediated the association between intolerance of uncertainty and anxiety, while Kashdan et al. [27] reported similar indirect effects in trauma survivors. Our findings extend this work by showing that indirect effects through distress are observed consistently across depression, anxiety, and stress as mediators and across physical, psychological, and general QoL as outcomes in the breast cancer context.
No indirect effects were significant at baseline despite strong bivariate associations. The most parsimonious explanation is that indirect effects are estimated imprecisely with small sample sizes. Moreover, the stronger cross-sectional associations at follow-up yielded larger and more stable product-of-coefficients estimates. Importantly, the follow-up models used concurrent data, meaning that all variables were measured at the same timepoint. These findings therefore represent cross-sectional indirect effects and should be interpreted as statistical associations rather than evidence of causal mediation [28]. Stein et al. [29] similarly cautioned that concurrent indirect effects may not replicate in cross-lag designs and recommended prospective tests with larger samples and additional assessment points.
Hierarchical regression results revealed that concurrent PI significantly predicted follow-up psychological QoL, general QoL, and anxiety after controlling for autoregressive effects, aligning with the longitudinal study by Al-Abbadey et al. [21] in which psychological flexibility predicted anxiety, depression, stress, and QoL in cancer survivors over three months. The observation that baseline PI contributed unique predictive variance only for anxiety is notable given that anxiety has been identified as a particularly persistent distress dimension in breast cancer [30,31], though this isolated finding requires replication. In contrast, PI did not predict social QoL, suggesting that social relationships in this population may be more closely associated with external interpersonal factors such as social support availability and relationship quality than with internal psychological processes [32,33]. This is consistent with our severity classification analysis, in which social QoL was the domain most consistently differentiated by emotional distress severity across all three DASS-21 subscales,pointing to social QoL as a sensitive indicator of distress burden potentially driven by relational rather than intrapersonal mechanisms.
From a clinical perspective, anxiety severity was associated with impairment across all five QoL domains, whereas depression and stress each differentiated only selected domains. This is consistent with evidence that anxiety co-occurs with prognostic uncertainty and fear of recurrence in breast cancer [11,34] and may be more strongly associated with global QoL deterioration than depression in long-term survivors [35]. Current NCCN guidelines recommend routine distress screening in oncology settings [36]; if replicated in adequately powered studies, our findings would suggest that incorporating a brief measure of PI alongside conventional distress measures may warrant investigation. Given the transdiagnostic nature of PI [20,21], ACT-based interventions that simultaneously address multiple distress dimensions [10,37] have shown feasibility in breast cancer populations [11,12,38] and represent a promising avenue. Future adequately powered prospective studies with three or more assessment points and structural equation modelling [39,40] are needed to establish the temporal sequence of these associations and provide more robust estimates of indirect effects.
This study has several limitations. The sample comprised 40 women from a single Portuguese radiotherapy service, which limits statistical power and generalisability. With N = 40, bootstrapped mediation has adequate power to detect only large indirect effects; Fritz and MacKinnon [23] estimated that small-to-medium indirect effects require N ≥ 148 using bias-corrected bootstrap. Accordingly, the null findings for baseline and change-score models may reflect insufficient power rather than genuine absence of indirect effects, and the significant follow-up results should be interpreted as preliminary. We applied Benjamini–Hochberg correction to the Kruskal–Wallis analyses but did not adjust for multiplicity across the 27 mediation or 5 regression models; consequently, some significant findings may represent false positives, and the follow-up results should be interpreted as a pattern requiring replication rather than as individually confirmed effects. The follow-up mediation models used concurrent data, precluding causal inference. Item-level data were unavailable, preventing recomputation of internal consistency, and no demographic or clinical covariates beyond age and cancer stage were available. As a secondary analysis, this study was constrained by the original study design and available variables [41,42].
Future research should replicate these findings in larger, prospectively designed samples with multiple assessment points and use structural equation modeling to test longitudinal mediation. Investigating ACT-based interventions targeting psychological inflexibility and multiple distress dimensions, as well as incorporating PI alongside routine distress screening, may improve identification and support of breast cancer patients at risk for reduced QoL.

5. Conclusions

In conclusion, these exploratory findings suggest that emotional distress may partially account for the cross-sectional association between PI and multiple QoL domains in women with non-metastatic breast cancer, consistent with predictions from the ACT model. Given the small sample and concurrent measurement, these results should be regarded as hypothesis-generating. Replication in adequately powered prospective samples is essential to establish temporal precedence and inform the design of targeted interventions [43].

Supplementary Materials

The following supporting information can be downloaded at: Table S6: title “Pearson Correlation Matrix – Baseline (M0)”; Table S7: title “Pearson Correlation Matrix – Follow up (M2)”; Table S8: title “Pearson Correlation Matrix – Change Scores (Δ)”.

Author Contributions

Conceptualization, I.M. and Y.S.; methodology, I.M.; formal analysis, I.M.; resources, I.M.; data curation, I.M.; writing—original draft preparation, I.M.; writing—review and editing, I.M.; visualization, I.M.; supervision, Y.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Ethical review and approval were waived for this study due to this study is a secondary analysis of a publicly available fully anonymized dataset.

Data Availability Statement

The dataset analysed in this study is publicly available via Mendeley Data (DOI: 10.17632/8yz89ct4br.1) [17].

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
ACT Acceptance and Commitment Therapy
BC Breast Cancer
PI Psychological Inflexibility
QoL Quality of Life

Appendix A

Table A1. “Descriptive Statistics for All Measures at M0 and M2”.
Table A1. “Descriptive Statistics for All Measures at M0 and M2”.
Measure Time n M SD Mdn Skew Kurt SW p
AAQ-II M0 40 17.35 9.32 17.00 0.61 -0.76 .003
AAQ-II M2 40 15.95 7.71 14.00 0.60 -0.77 .004
DASS Depression M0 40 4.08 5.32 2.00 1.30 0.69 <.001
DASS Depression M2 40 3.35 5.13 1.00 1.89 2.99 <.001
DASS Anxiety M0 39 4.03 4.75 3.00 1.34 1.47 <.001
DASS Anxiety M2 40 3.75 4.93 1.50 1.64 2.36 <.001
DASS Stress M0 39 5.74 5.14 5.00 0.90 -0.26 .001
DASS Stress M2 40 4.70 4.25 4.50 1.50 3.48 <.001
QoL Physical M0 40 62.77 20.04 64.29 0.06 -0.80 .395
QoL Physical M2 40 66.34 17.86 69.64 -0.18 -0.91 .331
QoL Psychological M0 40 69.48 19.11 70.83 -0.23 -1.00 .213
QoL Psychological M2 40 70.52 18.40 75.00 -0.76 -0.19 .016
QoL Social M0 40 68.54 15.84 75.00 -0.47 -0.27 .042
QoL Social M2 40 67.50 17.38 66.67 -0.29 -0.73 .147
QoL Environmental M0 39 63.46 16.97 62.50 0.33 -0.65 .359
QoL Environmental M2 40 63.28 17.97 65.62 0.11 -0.63 .450
QoL General M0 40 61.88 15.75 62.50 -0.36 -0.78 .008
QoL General M2 40 63.75 15.45 62.50 -0.18 -0.28 .008
Note. SW p = Shapiro-Wilk test p-value. Skew = skewness; Kurt = excess kurtosis.
Table A2. “DASS-21 Severity Classification: n (%) at M0 and M2”.
Table A2. “DASS-21 Severity Classification: n (%) at M0 and M2”.
Subscale Time Normal Mild Moderate Severe Ext. Severe
Depression M0 28 (70.0%) 2 (5.0%) 5 (12.5%) 2 (5.0%) 3 (7.5%)
Depression M2 29 (72.5%) 3 (7.5%) 4 (10.0%) 1 (2.5%) 3 (7.5%)
Anxiety M0 22 (56.4%) 6 (15.4%) 3 (7.7%) 3 (7.7%) 5 (12.8%)
Anxiety M2 26 (65.0%) 4 (10.0%) 3 (7.5%) 2 (5.0%) 5 (12.5%)
Stress M0 27 (69.2%) 4 (10.3%) 3 (7.7%) 3 (7.7%) 2 (5.1%)
Stress M2 34 (85.0%) 2 (5.0%) 2 (5.0%) 1 (2.5%) 1 (2.5%)
Note. Severity bands based on DASS-21 manual cut-offs [18]. Ext. Severe = Extremely Severe.
Table A3. Paired Comparisons: M0 vs M2 (N = 40).
Table A3. Paired Comparisons: M0 vs M2 (N = 40).
Measure M (M0) M (M2) Δ Test p d Sig
AAQ-II 17.35 15.95 -1.40 Wilcoxon .493 -0.20 ns
DASS Depression 4.08 3.35 -0.72 Wilcoxon .423 -0.16 ns
DASS Anxiety 4.03 3.72 -0.31 Wilcoxon .957 -0.07 ns
DASS Stress 5.74 4.59 -1.15 Wilcoxon .126 -0.28 ns
QoL Physical 62.77 66.34 3.57 Paired t .103 0.26 ns
QoL Psychological 69.48 70.52 1.04 Wilcoxon .843 0.08 ns
QoL Social 68.54 67.50 -1.04 Wilcoxon .500 -0.09 ns
QoL Environmental 63.46 63.70 0.24 Paired t .882 0.02 ns
QoL General 61.88 63.75 1.88 Wilcoxon .409 0.15 ns
Note. Wilcoxon signed-rank test used when Shapiro-Wilk test on difference scores was significant (p < .05); otherwise paired t-test. d = Cohen’s d for paired samples.
Table A4. “Theory-Driven Mediation Results: AAQ-II → DASS-21 → WHOQOL-BREF (Bootstrap 5000, BCa CIs)”.
Table A4. “Theory-Driven Mediation Results: AAQ-II → DASS-21 → WHOQOL-BREF (Bootstrap 5000, BCa CIs)”.
Timepoint Mediator Outcome Indirect [95% CI] p Direct Total % Med
Baseline (M0) Depression Physical -0.133 [-1.07, 0.17] .513 -1.25 -1.39 9.6%
Depression Psychological 0.025 [-0.40, 0.33] .874 -1.67 -1.64 -1.5%
Depression General 0.200 [-0.34, 0.41] .297 -1.56 -1.36 -14.7%
Anxiety Physical -0.151 [-1.07, 0.08] .370 -1.25 -1.40 10.8%
Anxiety Psychological -0.010 [-0.72, 0.16] .903 -1.68 -1.69 0.6%
Anxiety General 0.186 [-0.41, 0.33] .316 -1.59 -1.40 -13.3%
Stress Physical 0.096 [-0.50, 0.46] .673 -1.49 -1.39 -6.9%
Stress Psychological 0.227 [-0.08, 0.61] .156 -1.87 -1.64 -13.8%
Stress General 0.301 [-0.08, 0.55] .092 -1.66 -1.36 -22.1%
Follow-up (M2) Depression Physical -0.661 [-1.20, -0.32]* .002 -0.79 -1.45 45.7%
Depression Psychological -0.845 [-1.45, -0.37]* <.001 -0.93 -1.77 47.7%
Depression General -0.573 [-1.03, -0.13]* .009 -0.71 -1.29 44.5%
Anxiety Physical -0.739 [-1.36, -0.50]* <.001 -0.71 -1.45 51.1%
Anxiety Psychological -0.830 [-1.43, -0.26]* .007 -0.94 -1.77 46.9%
Anxiety General -0.551 [-1.00, -0.07]* .023 -0.74 -1.29 42.8%
Stress Physical -0.474 [-0.89, -0.11]* .022 -0.97 -1.45 32.8%
Stress Psychological -0.723 [-1.20, -0.18]* .005 -1.05 -1.77 40.8%
Stress General -0.628 [-0.99, -0.17]* .008 -0.66 -1.29 48.8%
Change (Δ) Depression Physical -0.126 [-0.53, 0.12] .480 -0.08 -0.20 61.6%
Depression Psychological -0.133 [-0.64, 0.06] .468 -0.46 -0.59 22.4%
Depression General -0.084 [-0.63, 0.02] .405 -0.52 -0.60 13.9%
Anxiety Physical -0.035 [-0.33, 0.28] .812 -0.15 -0.18 19.5%
Anxiety Psychological -0.035 [-0.35, 0.19] .817 -0.58 -0.61 5.6%
Anxiety General -0.028 [-0.34, 0.12] .768 -0.60 -0.63 4.4%
Stress Physical -0.059 [-0.35, 0.09] .545 -0.16 -0.22 26.9%
Stress Psychological -0.037 [-0.17, 0.12] .776 -0.57 -0.61 6.1%
Stress General -0.037 [-0.24, 0.08] .696 -0.56 -0.60 6.2%
Note. * p < .05 (95% BCa CI excludes zero). * p < .05 (95% BCa CI excludes zero). % Med = proportion of total effect mediated; values for non-significant indirect effects are unstable and should not be interpreted substantively [23]. Direct = direct effect (c’ path). Total = total effect (c path). Indirect effects tested via bootstrapped product of coefficients (5,000 resamples, BCa confidence intervals).
Table A5. “Summary of Hierarchical Regression Analyses for Untested Outcomes at M2.
Table A5. “Summary of Hierarchical Regression Analyses for Untested Outcomes at M2.
Outcome R² S1 R² S2 ΔR² AAQ M2 (S2) R² S3 AAQ M2 (S3) AAQ M0 (S3)
QoL Psychological .606 .700 .094 -.97** .703 -.91** -.18
QoL Social .603 .609 .006 -.23 .609 -.21 -.07
QoL Environmental .698 .729 .031 -.51† .735 -.64* .24
QoL General .438 .522 .084 -.75* .523 -.71* -.10
DASS Anxiety .416 .538 .122 .26** .593 .15 .20*
Note. S1/S2/S3 = regression step. B values shown are unstandardised coefficients. ΔR² = change from Step 1 to Step 2. * p < .05, ** p < .01, † p < .10.
Table A6. “Kruskal-Wallis Tests: QoL Domains by DASS-21 Severity Bands at Baseline”.
Table A6. “Kruskal-Wallis Tests: QoL Domains by DASS-21 Severity Bands at Baseline”.
DASS QoL Domain H df p p (adj) Sig
Anxiety Physical 14.99 4 .005 .016 *
Anxiety Psychological 15.49 4 .004 .016 *
Anxiety Social 20.41 4 <.001 .006 **
Anxiety Environmental 11.03 4 .026 .049 *
Anxiety General 14.11 4 .007 .017 *
Depression Physical 11.84 4 .019 .040 *
Depression Psychological 9.70 4 .046 .076 ns
Depression Social 16.67 4 .002 .016 *
Depression Environmental 4.33 4 .363 .411 ns
Depression General 7.67 4 .104 .156 ns
Stress Physical 6.21 4 .184 .251 ns
Stress Psychological 5.31 4 .257 .321 ns
Stress Social 14.66 4 .005 .016 *
Stress Environmental 4.17 4 .384 .411 ns
Stress General 3.75 4 .441 .441 ns
Note. H = Kruskal-Wallis test statistic. p (adj) = Benjamini-Hochberg adjusted p-value. * p_adj < .05, ** p_adj < .01.

References

  1. Bray, F; Laversanne, M; Sung, H; Ferlay, J; Siegel, RL; Soerjomataram, I; et al. Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2024, 74(3), 229–263. [Google Scholar] [CrossRef] [PubMed]
  2. Penberthy, JK; Stewart, AL; Centeno, CF; Penberthy, DR. Psychological Aspects of Breast Cancer. Psychiatr Clin North Am. 2023, 46(3), 551–570. [Google Scholar] [CrossRef] [PubMed]
  3. Carreira, H; Williams, R; Müller, M; Harewood, R; Stanway, S; Bhaskaran, K. Associations between Breast Cancer Survivorship and Adverse Mental Health Outcomes: A Systematic Review. J Natl Cancer Inst. 2018, 110(12), 1311–1327. [Google Scholar] [CrossRef]
  4. Wang, YH; Li, JQ; Shi, JF; Que, JY; Liu, JJ; Lappin, JM; et al. Depression and Anxiety in Relation to Cancer Incidence and Mortality: A Systematic Review and Meta-Analysis of Cohort Studies. Mol Psychiatry 2020, 25(7), 1487–1499. [Google Scholar] [CrossRef]
  5. Mitchell, AJ; Chan, M; Bhatti, H; Halton, M; Grassi, L; Johansen, C; et al. Prevalence of Depression, Anxiety, and Adjustment Disorder in Oncological, Haematological, and Palliative-Care Settings: A Meta-Analysis of 94 Interview-Based Studies. Lancet Oncol. 2011, 12(2), 160–174. [Google Scholar] [CrossRef]
  6. Hayes, SC; Strosahl, KD; Wilson, KG. Acceptance and Commitment Therapy: The Process and Practice of Mindful Change, 2nd Ed ed; Guilford Press: New York, 2012. [Google Scholar]
  7. Bond, FW; Hayes, SC; Baer, RA; Carpenter, KM; Guenole, N; Orcutt, HK; et al. Preliminary Psychometric Properties of the Acceptance and Action Questionnaire-II: A Revised Measure of Psychological Inflexibility and Experiential Avoidance. Behav Ther. 2011, 42(4), 676–688. [Google Scholar] [CrossRef]
  8. Zhang, CQ; Leeming, E; Smith, P; Chung, PK; Hagger, MS; Hayes, SC. Acceptance and Commitment Therapy for Health Behavior Change: A Contextually-Driven Approach. Front Psychol. 2018, 8, 2350. [Google Scholar] [CrossRef]
  9. Fashler, SR; Weinrib, AZ; Azam, MA; Katz, J. The Use of Acceptance and Commitment Therapy in Oncology Settings: A Narrative Review. Psychol Rep. 2018, 121(2), 229–252. [Google Scholar] [CrossRef]
  10. Li, H; Wu, J; Ni, Q; Zhang, J; Wang, Y; He, G. Systematic Review and Meta-Analysis of Effectiveness of Acceptance and Commitment Therapy in Patients with Breast Cancer. Nurs Res. 2021, 70(4), E152–E160. [Google Scholar] [CrossRef]
  11. Johns, SA; Stutz, PV; Talib, TL; Cohee, AA; Beck-Coon, KA; Brown, LF; et al. Acceptance and Commitment Therapy for Breast Cancer Survivors with Fear of Cancer Recurrence: A 3-Arm Pilot Randomized Controlled Trial. Cancer 2020, 126(1), 211–218. [Google Scholar] [CrossRef] [PubMed]
  12. Ghorbani, V; Zanjani, Z; Omidi, A; Sarvizadeh, M. Efficacy of Acceptance and Commitment Therapy on Depression, Pain Acceptance, and Psychological Flexibility in Married Women with Breast Cancer: A Pre- and Post-Test Clinical Trial. Trends Psychiatry Psychother. 2021, 43(2), 126–133. [Google Scholar] [CrossRef]
  13. Yela, JR; Gómez-Martínez, MÁ; Crego, A; Jiménez-García, C. Reductions in Experiential Avoidance Explain Changes in Anxiety, Depression and Well-Being after a Mindfulness and Self-Compassion (MSC) Training. Psychol Psychother. 2022, 95(1), 72–86. [Google Scholar] [CrossRef] [PubMed]
  14. Mohammadkhani, P; Forouzan, AS; Hooshyari, Z; Abasi, I. The Role of Neuroticism and Experiential Avoidance in Predicting Anxiety and Depression Symptoms: Mediating Role of Emotion Regulation. Iran J Psychiatry Behav Sci. 2016, 10(3), E5047. [Google Scholar] [CrossRef]
  15. Klimczak, KS; San Miguel, GG; Mukasa, MN; Twohig, MP; Levin, ME. A Systematic Review and Meta-Analysis of Self-Guided Online Acceptance and Commitment Therapy as a Transdiagnostic Self-Help Intervention. Cogn Behav Ther. 2023, 52(3), 269–294. [Google Scholar] [CrossRef]
  16. Trindade, IA; Marta-Simões, J; Mendes, AL; Borrego, M; Ponte, A; Carvalho, C; et al. A Longitudinal Preliminary Analysis on the Role of Experiential Avoidance in Breast Cancer Patients’ Reported Health Outcomes. Psychooncology 2020, 29(4), 812–814. [Google Scholar] [CrossRef] [PubMed]
  17. Trindade, IA. Experiential Avoidance and Breast Cancer [Dataset]. In Mendeley Data; 2019. [Google Scholar] [CrossRef]
  18. Lovibond, SH; Lovibond, PF. Manual for the Depression Anxiety Stress Scales, 2nd Ed ed; Psychology Foundation of Australia: Sydney, 1995. [Google Scholar]
  19. The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment. Psychol Med. 1998, 28(3), 551–558. [Google Scholar] [CrossRef]
  20. Akbari, M; Seydavi, M; Hosseini, ZS; Krafft, J; Levin, ME. Experiential Avoidance in Depression, Anxiety, Obsessive-Compulsive Related, and Posttraumatic Stress Disorders: A Comprehensive Systematic Review and Meta-Analysis. J Context Behav Sci. 2022, 24, 65–78. [Google Scholar] [CrossRef]
  21. Al-Abbadey, M; Tomescu-Stachie, S; Kaklamanou, D; Jarrett, N; Merwood, A; Tyndall, I; et al. The Role of Psychological Flexibility in Relation to Health Outcomes in People in Remission from Cancer. Br J Health Psychol. 2025, 30(3), E12807. [Google Scholar] [CrossRef]
  22. Tingley, D; Yamamoto, T; Hirose, K; Keele, L; Imai, K. Mediation: R Package for Causal Mediation Analysis. J Stat Softw. 2014, 59(5), 1–38. [Google Scholar] [CrossRef]
  23. Fritz, MS; MacKinnon, DP. Required Sample Size to Detect the Mediated Effect. Psychol Sci. 2007, 18(3), 233–239. [Google Scholar] [CrossRef]
  24. Donahue, ML; Levin, ME; Olson, K; Panza, E; Lillis, J. Examining the Role of Experiential Avoidance and Valued Action in the Negative Effects of Weight Self-Stigma. J Behav Med. 2023, 46(3), 517–524. [Google Scholar] [CrossRef]
  25. Bardeen, JR; Fergus, TA; Orcutt, HK. Experiential Avoidance as a Moderator of the Relationship between Anxiety Sensitivity and Perceived Stress. Behav Ther. 2013, 44(3), 459–469. [Google Scholar] [CrossRef]
  26. Panjwani, AA; Applebaum, AJ; Revenson, TA; Erblich, J; Rosenfeld, B. Intolerance of Uncertainty, Experiential Avoidance, and Trust in Physician: A Moderated Mediation Analysis of Emotional Distress in Advanced Cancer. J Behav Med. 2024, 47(1), 71–81. [Google Scholar] [CrossRef]
  27. Kashdan, TB; Morina, N; Priebe, S. Post-Traumatic Stress Disorder, Social Anxiety Disorder, and Depression in Survivors of the Kosovo War: Experiential Avoidance as a Contributor to Distress and Quality of Life. J Anxiety Disord. 2009, 23(2), 185–196. [Google Scholar] [CrossRef]
  28. Bullock, JG; Green, DP; Ha, SE. Yes, but What’s the Mechanism? (Don’t Expect an Easy Answer). J Pers Soc Psychol. 2010, 98(4), 550–558. [Google Scholar] [CrossRef] [PubMed]
  29. Stein, AT; Medina, JL; Rosenfield, D; Otto, MW; Smits, JAJ. Examining Experiential Avoidance as a Mediator of the Relation between Anxiety Sensitivity and Depressive Symptoms. Cogn Behav Ther. 2019, 49(1), 41–54. [Google Scholar] [CrossRef]
  30. Burgess, C; Cornelius, V; Love, S; Graham, J; Richards, M; Ramirez, A. Depression and Anxiety in Women with Early Breast Cancer: Five Year Observational Cohort Study. BMJ 2005, 330(7493), 702. [Google Scholar] [CrossRef] [PubMed]
  31. Lim, CC; Devi, MK; Ang, E. Anxiety in Women with Breast Cancer Undergoing Treatment: A Systematic Review. Int J Evid Based Healthc. 2011, 9(3), 215–235. [Google Scholar] [PubMed]
  32. Hughes, S; Jaremka, LM; Alfano, CM; Glaser, R; Povoski, SP; Lipari, AM; et al. Social Support Predicts Inflammation, Pain, and Depressive Symptoms: Longitudinal Relationships among Breast Cancer Survivors. Psychoneuroendocrinology 2014, 42, 38–44. [Google Scholar] [CrossRef]
  33. Marinkovic, M; Djordjevic, N; Djordjevic, L; Ignjatovic, N; Djordjevic, M; Karanikolic, V. Assessment of the Quality of Life in Breast Cancer Depending on the Surgical Treatment. Support Care Cancer 2021, 29(6), 3257–3266. [Google Scholar] [CrossRef]
  34. Simard, S; Thewes, B; Humphris, G; Dixon, M; Hayden, C; Mireskandari, S; et al. Fear of Cancer Recurrence in Adult Cancer Survivors: A Systematic Review of Quantitative Studies. J Cancer Surviv. 2013, 7(3), 300–322. [Google Scholar] [CrossRef]
  35. Brunault, P; Toledano, A; Aguerre, C; Suzanne, I; Garaud, P; Trzepidur-Edom, M; et al. Impact of Late Treatment-Related Radiotherapy Toxicity, Depression, and Anxiety on Quality of Life in Long-Term Breast Cancer Survivors. Bull Cancer 2012, 99(5), 589–598. [Google Scholar] [CrossRef]
  36. Riba, MB; Donovan, KA; Andersen, B; Braun, I; Breitbart, WS; Brewer, BW; et al. Distress Management, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019, 17(10), 1229–1249. [Google Scholar] [CrossRef] [PubMed]
  37. Graham, CD; Gouick, J; Kravariti, E; Gillanders, D. A Systematic Review of the Use of Acceptance and Commitment Therapy (ACT) in Chronic Disease and Long-Term Conditions. Clin Psychol Rev. 2016, 46, 46–58. [Google Scholar] [CrossRef]
  38. Gonzalez-Fernandez, S; Fernandez-Rodriguez, C. Acceptance and Commitment Therapy in Cancer: Review of Applications and Findings. Behav Med. 2019, 45(3), 255–269. [Google Scholar] [CrossRef] [PubMed]
  39. MacKinnon, DP; Fairchild, AJ; Fritz, MS. Mediation Analysis. Annu Rev Psychol. 2007, 58, 593–614. [Google Scholar] [CrossRef]
  40. Hayes, AF. Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach, 3rd Ed ed; Guilford Press: New York, 2022. [Google Scholar]
  41. Cheng, HG; Phillips, MR. Secondary Analysis of Existing Data: Opportunities and Implementation. Shanghai Arch Psychiatry 2014, 26(6), 371–375. [Google Scholar]
  42. Doolan, DM; Froelicher, ES. Using an Existing Data Set to Answer New Research Questions: A Methodological Review. Res Theory Nurs Pract. 2009, 23(3), 203–215. [Google Scholar] [CrossRef] [PubMed]
  43. Hulbert-Williams, NJ; Storey, L; Wilson, KG. Psychological Interventions for Patients with Cancer: Psychological Flexibility and the Potential Utility of Acceptance and Commitment Therapy. Eur J Cancer Care 2015, 24(1), 15–27. [Google Scholar] [CrossRef]
Figure 1. Conceptual mediation model. Psychological inflexibility (AAQ-II) is hypothesised to affect quality of life (WHOQOL-BREF) both directly (c’ path) and indirectly through emotional distress (DASS-21: depression, anxiety, stress). The indirect effect (ab) represents the product of the a and b paths.
Figure 1. Conceptual mediation model. Psychological inflexibility (AAQ-II) is hypothesised to affect quality of life (WHOQOL-BREF) both directly (c’ path) and indirectly through emotional distress (DASS-21: depression, anxiety, stress). The indirect effect (ab) represents the product of the a and b paths.
Preprints 206225 g001
Figure 2. Heatmap of indirect effects across all 27 mediation models (3 DASS-21 mediators × 3 WHOQOL-BREF outcomes × 3 timepoints). Cell values represent point estimates of the indirect effect with 95% BCa confidence intervals in brackets. White dots denote statistically significant indirect effects (p < .05). Colour intensity reflects effect magnitude: blue = positive (suppression), red = negative (mediation in the expected direction).
Figure 2. Heatmap of indirect effects across all 27 mediation models (3 DASS-21 mediators × 3 WHOQOL-BREF outcomes × 3 timepoints). Cell values represent point estimates of the indirect effect with 95% BCa confidence intervals in brackets. White dots denote statistically significant indirect effects (p < .05). Colour intensity reflects effect magnitude: blue = positive (suppression), red = negative (mediation in the expected direction).
Preprints 206225 g002
Figure 3. Path diagram showing indirect effects of psychological inflexibility (AAQ-II) on quality of life through depression (DASS-21) at 2-month follow-up (M2). Solid arrows indicate significant paths; dashed arrows indicate non-significant direct effects (c’ paths). Indirect effects (ab), proportions mediated, and significance levels are presented for physical, psychological, and general QoL outcomes.
Figure 3. Path diagram showing indirect effects of psychological inflexibility (AAQ-II) on quality of life through depression (DASS-21) at 2-month follow-up (M2). Solid arrows indicate significant paths; dashed arrows indicate non-significant direct effects (c’ paths). Indirect effects (ab), proportions mediated, and significance levels are presented for physical, psychological, and general QoL outcomes.
Preprints 206225 g003
Figure 4. Mediation contrast across timepoints for an exemplar pathway (AAQ-II → Depression → Psychological QoL). Significant indirect effects emerged exclusively at follow-up (M2), transitioning from non-significant at baseline (indirect = −0.025, p = .874) to significant at follow-up (indirect = −0.845, p < .001). Change-score models remained non-significant (indirect = −0.133, p = .468).
Figure 4. Mediation contrast across timepoints for an exemplar pathway (AAQ-II → Depression → Psychological QoL). Significant indirect effects emerged exclusively at follow-up (M2), transitioning from non-significant at baseline (indirect = −0.025, p = .874) to significant at follow-up (indirect = −0.845, p < .001). Change-score models remained non-significant (indirect = −0.133, p = .468).
Preprints 206225 g004
Figure 5. Quality of life scores (WHOQOL-BREF domains) by DASS-21 clinical severity classification at baseline. Each panel represents a QoL domain (columns) by DASS-21 subscale (rows) combination. Boxes represent interquartile ranges with median lines; whiskers extend to 1.5 × IQR.
Figure 5. Quality of life scores (WHOQOL-BREF domains) by DASS-21 clinical severity classification at baseline. Each panel represents a QoL domain (columns) by DASS-21 subscale (rows) combination. Boxes represent interquartile ranges with median lines; whiskers extend to 1.5 × IQR.
Preprints 206225 g005
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2026 MDPI (Basel, Switzerland) unless otherwise stated